The levels of Raftlin in the control, CRSwNP, and CRSwNP + SK groups were 82.2 ± 15.1, 78.6 ± 12.9, and 100.5 ± 18.6 pg/mL, respectively, with no significant differences between the CRSwNP and CRSwNP + SK groups when compared to the control group (Figure 1A). This evidence concerns the gene RFTN1 and chronic rhinosinusitis with nasal polyps.